|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 14/725 | (2006.01) |
| C07K 14/7051 | (2013.01) | ||
| A61K 31/505 | (2006.01) | ||
| A61K 31/7088 | (2013.01) | ||
| A61K 45/06 | (2013.01) | ||
| A61K 38/00 | (2013.01) | ||
| A61K 35/17 | (2013.01) | ||
| C12N 5/0636 | (2013.01) | ||
| C12N2510/00 | (2013.01) | ||
| A61P 35/02 | (2018.01) | ||
| A61K2039/5156 | (2013.01) | ||
| A61K2039/5158 | (2013.01) | ||
| A61K 39/001112 | (2018.08) |
| (11) | Number of the document | 3959235 |
| (13) | Kind of document | T |
| (96) | European patent application number | 20728258.3 |
| Date of filing the European patent application | 2020-04-24 | |
| (97) | Date of publication of the European application | 2022-03-02 |
| (45) | Date of publication and mention of the grant of the patent | 2023-07-26 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2020/029775 |
| Date | 2020-04-24 |
| (87) | Number | WO 2020/219848 |
| Date | 2020-10-29 |
| (30) | Number | Date | Country code |
| 201962839455 P | 2019-04-26 | US | |
| 202063005041 P | 2020-04-03 | US |
| (72) |
PERTEL, Thomas Charles , US
SASU, Barbra Johnson , US
LEONARD, Mark W. , US
|
| (73) |
Allogene Therapeutics, Inc. ,
210 E. Grand Avenue, South San Francisco, CA 94080,
US
|
| (54) | RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF |
| RITUXIMAB-RESISTANT CHIMERIC ANTIGEN RECEPTORS AND USES THEREOF |